Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Chemico-Biological Interactions

• Publication date

  2000-01-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0009-2797(99)00144-1PMID 10658902
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brequinar sodium

  2004cited by this paper
• Expression, purification, and characterization of histidine-tagged rat and human flavoenzyme dihydroorotate dehydrogenase.

  1998cited by this paper
• Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives.

  1998cited by this paper
• Biological effects of the dihydroorotate dehydrogenase inhibitor polyporic acid, a toxic constituent of the mushroom Hapalopilus rutilans , in rats and humans

  1998cited by this paper
• Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide.

  1998cited by this paper
• Rat dihydroorotate dehydrogenase: isolation of the recombinant enzyme from mitochondria of insect cells.

  1997cited by this paper
• New Targets for Antimalarial Drug Discovery

  1997cited by this paper
• Preparation of Naphthoquinone Derivatives from Plumbagin and Their Ichthyotoxicity

  1997cited by this paper
• Synthesis and protozoocidal activities of quinones

  1996cited by this paper
• Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.

  1996cited by this paper
• Functional expression of a fragment of human dihydroorotate dehydrogenase by means of the baculovirus expression vector system, and kinetic investigation of the purified recombinant enzyme.

  1996cited by this paper
• Chemotherapy of human and animal coccidioses: state and perspectives

  1996cited by this paper
• Atovaquone as long‐term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance

  1996cited by this paper
• Importance of Ribonucleotide Availability to Proliferating T-lymphocytes from Healthy Humans

  1995cited by this paper
• Localization of dihydroorotate oxidase in myocardium and kidney cortex of the rat

  1995cited by this paper
• Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.

  1995cited by this paper
• Kinetics of slow and tight-binding inhibitors.

  1995cited by this paper
• Recombinant human dihydroorotate dehydrogenase: expression, purification, and characterization of a catalytically functional truncated enzyme.

  1995cited by this paper
• Copyright � 1995, American Society for Microbiology Effects of Atovaquone and Other Inhibitors on

  1994cited by this paper
• Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum.

  1994cited by this paper
• Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80).

  1992cited by this paper
• Differential susceptibility of dihydroorotate dehydrogenase/oxidase to Brequinar Sodium (NSC 368 390) in vitro.

  1992cited by this paper
• Effect of hydroxy substituent position on 1,4-naphthoquinone toxicity to rat hepatocytes.

  1991cited by this paper
• Butylmalonate is a transition state analogue for aminocylase I

  1989cited by this paper
• Purification and properties of the bovine liver mitochondrial dihydroorotate dehydrogenase.

  1986cited by this paper
• The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions

  1982cited by this paper
• Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis.

  1980cited by this paper
• Fundamentals of Enzyme Kinetics

  1979cited by this paper
• Inhibition of synthesis of pyrimidine nucleotides by 2-hydroxy-3-(3,3-dichloroallyl)-1,4-naphthoquinone.

  1979cited by this paper

• NK-A 17E-233I: a novel competitive inhibitor of human dihydroorotate dehydrogenase (DHODH) for cancer therapy

  2025cites this paper
• Interaction of brequinar and analogs with PD-L1: a molecular docking analysis

  2025cites this paper
• Chemical Synthetic Lethality Screens Identify Selective Drug Combinations against Pseudomonas aeruginosa.

  2025cites this paper
• Enhanced Anticancer Efficiency of Curcumin Co-Loaded Lawsone Solid Lipid Nanoparticles Against MCF-7 Breast Cancer Cell Lines: Optimization by Statistical JMP Software-Based Experimental Approach

  2025cites this paper
• Molecular analysis of the 2022 Mpox outbreak and antiviral activity of dihydroorotate dehydrogenase inhibitors against orthopoxviruses.

  2024cites this paper
• Tumor-Targeted Metal-Organic Framework for Improved Photodynamic Therapy and Inhibited Tumor Metastasis in Melanoma.

  2024cites this paper
• Screening for DAX1/EWS‐FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma

  2023cites this paper
• Tiratricol, a thyroid hormone metabolite, has potent inhibitory activity against human dihydroorotate dehydrogenase

  2023cites this paper
• Synthesis and evaluation of biological effects of modified graphene oxide nanoparticles containing Lawson (Henna extract) on gastric cancer cells

  2023cites this paper
• Medicinal chemistry approaches for the discovery of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors as antimalarial agents.

  2023cites this paper
• Toxic Effect of Lawsonia inermis Leaf Litter on Growth and Reproduction of Earthworm Eudrilus eugeniae

  2023cites this paper
• Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer.

  2023cites this paper
• Unveiling the Antiviral Capabilities of Targeting Human Dihydroorotate Dehydrogenase against SARS-CoV-2

  2023cites this paper
• Mitochondrial DHODH regulates hypoxia-inducible factor 1 expression in OTSCC.

  2022cites this paper
• Protein production, kinetic and biophysical characterization of three human dihydroorotate dehydrogenase mutants associated with Miller syndrome

  2022cites this paper
• Unveiling the membrane bound dihydroorotate: Quinone oxidoreductase from Staphylococcus aureus.

  2022cites this paper
• Discovery of a first-in-class inhibitor of sulfide:quinone oxidoreductase that protects against adverse cardiac remodeling and heart failure.

  2021cites this paper
• Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio

  2021cites this paper
• Atovaquone and Berberine Chloride Reduce SARS-CoV-2 Replication In Vitro

  2021cites this paper
• Active mitochondrial respiration in cancer: a target for the drug

  2021cites this paper
• Antimalarial Inhibitors Targeting Epigenetics or Mitochondria in Plasmodium falciparum: Recent Survey upon Synthesis and Biological Evaluation of Potential Drugs against Malaria

  2021cites this paper
• Bifunctional Naphtho[2,3-d][1,2,3]triazole-4,9-dione Compounds Exhibit Antitumor Effects In Vitro and In Vivo by Inhibiting Dihydroorotate Dehydrogenase and Inducing Reactive Oxygen Species Production.

  2020cites this paper
• Lichen Metabolites: An Overview of Some Secondary Metabolites and Their Biological Potential

  2020cites this paper
• The pathway to pyrimidines: The essential focus on dihydroorotate dehydrogenase, the mitochondrial enzyme coupled to the respiratory chain

  2020cites this paper
• Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase.

  2019cites this paper
• Phytophthora infestans Dihydroorotate Dehydrogenase Is a Potential Target for Chemical Control – A Comparison With the Enzyme From Solanum tuberosum

  2019cites this paper
• Dihydroorotate dehydrogenase inhibitors in anti-infective drug research.

  2019cites this paper
• Synthesis, Design, and Structure–Activity Relationship of the Pyrimidone Derivatives as Novel Selective Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase

  2018cites this paper
• Design, synthesis, and biological evaluation of novel substituted benzamide derivatives bearing a 1,2,3-triazole moiety as potent human dihydroorotate dehydrogenase inhibitors.

  2018cites this paper
• Lawsone-loaded Niosome and its antitumor activity in MCF-7 breast Cancer cell line: a Nano-herbal treatment for Cancer

  2018cites this paper
• Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria.

  2018cites this paper
• Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker

  2017cites this paper
• Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses

  2017cites this paper
• Effects of dihydroorotate dehydrogenase (DHODH) inhibitors on the growth of Theileria equi and Babesia caballi in vitro.

  2017cites this paper
• Dihydroorotate dehydrogenase: A drug target for the development of antimalarials.

  2017cites this paper
• Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis

  2017influential citation
• The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia

  2016cites this paper
• A high-throughput fluorescence-based assay for Plasmodium dihydroorotate dehydrogenase inhibitor screening.

  2016cites this paper
• Chapter 9 Bioambiant Preservation of Raw Hides Using Plant-Based Materials – A Green Technology to Reduce Tannery Waste Water Pollution

  2016cites this paper
• Development of ML390: A Human DHODH Inhibitor That Induces Differentiation in Acute Myeloid Leukemia.

  2016cites this paper
• A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity

  2015cites this paper
• Targeting of Helicobacter pylori thymidylate synthase ThyX by non-mitotoxic hydroxy-naphthoquinones

  2015cites this paper
• Essential Role of Mitochondria in Pyrimidine Metabolism

  2015cites this paper
• Design, synthesis, X-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase.

  2015cites this paper
• Original 2-(3-alkoxy-1H-pyrazol-1-yl)pyrimidine derivatives as inhibitors of human dihydroorotate dehydrogenase (DHODH).

  2015cites this paper
• UNIVERSIDADE FEDERAL DO PARANÁ FRANCISCO MENINO DESTÉFANIS VÍTOLA ANTILEISHMANIAL BIOCOMPOUNDS SCREENING ON SUBMERGED MYCELIAL CULTURE BROTHS OF TWELVE MACROMYCETE SPECIES CURITIBA 2008 FRANCISCO MENINO DESTÉFANIS VÍTOLA ANTILEISHMANIAL BIOCOMPOUNDS SCREENING ON SUBMERGED MYCELIAL CULTURE BROTH

  2014cites this paper
• Development of a Human Dihydroorotate Dehydrogenase (hDHODH) Pharma-Similarity Index Approach with Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors

  2014cites this paper
• Electrochemical studies on lawsone and its determination in henna (Lawsonia inermis) extract using glassy carbon electrode

  2014cites this paper
• Synthesis and biological evaluation of novel ferrocene-naphthoquinones as antiplasmodial agents.

  2013cites this paper
• Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation[S]

  2013cites this paper
• Class 1 Oxidoreductases

  2013influential citation
• How mitochondrial dysfunction affects zebrafish development and cardiovascular function: an in vivo model for testing mitochondria‐targeted drugs

  2013cites this paper
• A new method for the isolation and purification of Lawsone from Lawsonia Inermis and its ROS inhibitory activity

  2013cites this paper
• On dihydroorotate dehydrogenases and their inhibitors and uses.

  2013cites this paper
• Laccase‐Catalyzed CS and CC Coupling for a One‐Pot Synthesis of 1,4‐Naphthoquinone Sulfides and 1,4‐Naphthoquinone Sulfide Dimers

  2013cites this paper
• An aggregation sensing reporter identifies leflunomide and teriflunomide as polyglutamine aggregate inhibitors.

  2012influential citation
• Discovery of 4-hydroxy-1,6-naphthyridine-3-carbonitrile derivatives as novel PDE10A inhibitors.

  2012cites this paper
• Discovery of diverse human dihydroorotate dehydrogenase inhibitors as immunosuppressive agents by structure-based virtual screening.

  2012cites this paper
• Synthesis of fluorescent hydroxyl naphthalene-1,4-dione derivatives by a three-component reaction in water

  2011cites this paper
• 5-Hydroxy-1,4-naphthoquinone (juglone) and 2-hydroxy-1,4-naphthoquinone (lawsone) influence on jack bean urease activity: Elucidation of the difference in inhibition activity.

  2010cites this paper
• Biological Aspects of Metal Enolates

  2010cites this paper
• Antiplasmodial activity of quinones: roles of aziridinyl substituents and the inhibition of Plasmodium falciparum glutathione reductase.

  2010cites this paper
• Biological synthesis of silver and gold nanoparticles using apiin as reducing agent.

  2009cites this paper
• Noteworthy Secondary Metabolites Naphthoquinones - their Occurrence, Pharmacological Properties and Analysis

  2009cites this paper
• The structures of human dihydroorotate dehydrogenase with and without inhibitor reveal conformational flexibility in the inhibitor and substrate binding sites.

  2008cites this paper
• Tabebuia avellanedae extracts inhibit IL-2-independent T-lymphocyte activation and proliferation.

  2008cites this paper
• Defects in vesicle core induced by escherichia coli dihydroorotate dehydrogenase.

  2008cites this paper
• Dual binding mode of a novel series of DHODH inhibitors.

  2007cites this paper
• Functional Expression of Human Dihydroorotate Dehydrogenase (DHODH) in pyr4 Mutants of Ustilago maydis Allows Target Validation of DHODH Inhibitors In Vivo

  2007cites this paper
• Recombinant expression, purification, and kinetic and inhibitor characterisation of human site-1-protease.

  2007cites this paper
• Design and synthesis of potent inhibitors of the malaria parasite dihydroorotate dehydrogenase.

  2007cites this paper
• Crystallization and preliminary X-ray diffraction analysis of Leishmania major dihydroorotate dehydrogenase.

  2006cites this paper
• Embryo development alteration in rats treated with lapachol

  2006cites this paper
• Brequinar derivatives and species-specific drug design for dihydroorotate dehydrogenase.

  2006cites this paper
• Biochemical characterization of recombinant dihydroorotate dehydrogenase from the opportunistic pathogenic yeast Candida albicans

  2006cites this paper
• Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor.

  2006influential citation
• Synthesis and cytotoxicity of new aminoterpenylquinones.

  2005cites this paper
• Synthesis and antifungal activity of 2/3-arylthio- and 2,3-bis(arylthio)-5-hydroxy-/5-methoxy-1,4-naphthoquinones.

  2005cites this paper
• Pyrimidine pathways in health and disease.

  2005cites this paper
• Antioxidant and Immunomodulatory Constituents of Henna Leaves

  2004cites this paper
• Quantitative structure-activity relationship in aziridinyl-1,4-naphthoquinone antimalarials: study of theoretical correlations by the PM3 method.

  2004cites this paper
• Two different dihydroorotate dehydrogenases from yeast Saccharomyces kluyveri

  2004cites this paper
• Inhibitor binding in a class 2 dihydroorotate dehydrogenase causes variations in the membrane‐associated N‐terminal domain

  2004cites this paper
• Molecular biology and biochemistry of malarial parasite pyrimidine biosynthetic pathway.

  2003cites this paper
• Original research article Fetal growth in rats treated with lapachol

  2002cites this paper
• Reductive activation of terpenylnaphthoquinones.

  2002cites this paper
• Drosophila melanogaster dihydroorotate dehydrogenase: the N-terminus is important for biological function in vivo but not for catalytic properties in vitro.

  2002cites this paper
• Fetal growth in rats treated with lapachol.

  2002cites this paper
• E. coli dihydroorotate dehydrogenase reveals structural and functional distinctions between different classes of dihydroorotate dehydrogenases.

  2002cites this paper
• Malarial Dihydroorotate Dehydrogenase

  2002cites this paper
• Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate dehydrogenase.

  2001cites this paper
• Recombinant expression of N-terminal truncated mutants of the membrane bound mouse, rat and human flavoenzyme dihydroorotate dehydrogenase. A versatile tool to rate inhibitor effects?

  2001cites this paper
• Immunocytochemical detection of mitochondrial dihydroorotate dehydrogenase in human spermatozoa.

  2000cites this paper
• Inhibition and localization of human and rat dihydroorotate dehydrogenase.

  2000cites this paper